44511
44464
S&P/TSX
16004.40
+5.83
(0.04%)
S&P-CDNX
794.13
-5.22
(-0.65%)
S&P-500
2582.14
+3.29
(0.13%)
NASDAQ
6790.71
+7.92
(0.12%)
Dow
23430.33
+72.09
(0.31%)
Dollar
0.7810
+0.00063
(0.081%)
Oil
56.34
-0.08
(-0.14%)
Gold
1279.29
+3.99
(+0.31%)
Silver
16.956
+0.114
(+0.68%)


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

46008
Recent Trending
45580
48310
Castanet Proud Member of RTNDA Canada
Press Room